These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6095457)

  • 1. Targeting of daunorubicin by association with DNA or proteins: a review.
    Trouet A; Jollès G
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):64-72. PubMed ID: 6095457
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of daunorubicin.
    Benjamin RS
    Cancer Treat Rep; 1981; 65 Suppl 4():109-10. PubMed ID: 6955010
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 4. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and related anthracycline antibiotics.
    Brown JR
    Prog Med Chem; 1978; 15():125-64. PubMed ID: 400611
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity.
    Rahman A; Fumagalli A; Goodman A; Schein PS
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):45-55. PubMed ID: 6594763
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.
    Yeo W; Chan KK; Mukwaya G; Ross M; Leung WT; Ho S; Chan AT; Johnson PJ
    Cancer Chemother Pharmacol; 1999; 44(2):124-30. PubMed ID: 10412946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone.
    Dornberger K; Hübener R; Ihn W; Thrum H; Radics L
    J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.
    Yesair DW; Schwartzbach E; Shuck D; Denine EP; Asbell MA
    Cancer Res; 1972 Jun; 32(6):1177-83. PubMed ID: 5030818
    [No Abstract]   [Full Text] [Related]  

  • 13. Daunorubicin metabolism by rat tissue preparations.
    Bachur NR; Gee M
    J Pharmacol Exp Ther; 1971 Jun; 177(3):567-72. PubMed ID: 4398190
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis.
    Daniele B; De Vivo R; Perrone F; Lastoria S; Tambaro R; Izzo F; Fiore F; Vallone P; Pignata S
    Anticancer Res; 2000; 20(2B):1249-51. PubMed ID: 10810429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetic study of methotrexate and the anthracyclines].
    Lokiec F; Najean Y; Kadouche J
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXV. PubMed ID: 296375
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Ruboxyl (nitroxyl derivative of daunorubicin) on hepatic metastases of colorectal carcinoma].
    Konovalova NP; Volkova LM; Codacci-Pisanelli D; Seminara P; Franchi F
    Vopr Onkol; 2000; 46(4):438-41. PubMed ID: 11147420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of anthracycline--DNA complexes by circular dichroism.
    Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
    Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.